Literature DB >> 19021226

The evolution of lymph node assessment in breast cancer.

May Lynn Quan1, David McCready.   

Abstract

Lymph node evaluation remains integral in the management of breast cancer for prognostic and therapeutic purposes. The introduction of sentinel lymph node biopsy has revolutionized axillary surgery, presenting new challenges relating to clinical implications and quality which will be reviewed in this article.

Entities:  

Mesh：

Year:  2009        PMID： 19021226     DOI： 10.1002/jso.21201

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

Authors:  Pia R Mendoza; Hans E Grossniklaus
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Total adventitial resection of the cardia: 'optimal local resection' for tumours of the oesophagogastric junction.

Authors:  A J Botha; W Odendaal; V Patel; T Watcyn-Jones; U Mahadeva; F Chang; H Deere
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

3.  Three-dimensional optical coherence tomography for optical biopsy of lymph nodes and assessment of metastatic disease.

Authors:  Renu John; Steven G Adie; Eric J Chaney; Marina Marjanovic; Krishnarao V Tangella; Stephen A Boppart
Journal:  Ann Surg Oncol       Date:  2012-06-12       Impact factor: 5.344

4.  Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.

Authors:  Amy Cyr; Feng Gao; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

5.  Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma.

Authors:  Mingzhen Ying; Dawei Li; Linjun Yang; Mei Wang; Ning Wang; Ying Chen; Miaoxia He; Yajie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-14       Impact factor: 4.553

6.  Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes.

Authors:  A Francesca Setiadi; Nelson C Ray; Holbrook E Kohrt; Adam Kapelner; Valeria Carcamo-Cavazos; Edina B Levic; Sina Yadegarynia; Chris M van der Loos; Erich J Schwartz; Susan Holmes; Peter P Lee
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

7.  A Positive Node on Ultrasound-Guided Fine Needle Aspiration Predicts Higher Nodal Burden Than a Positive Sentinel Lymph Node Biopsy in Breast Carcinoma.

Authors:  M R Boland; R Ni Cearbhaill; K Fitzpatrick; S M Walsh; D Evoy; J Geraghty; J Rothwell; S McNally; A O'Doherty; C M Quinn; E W McDermott; R S Prichard
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

8.  High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer.

Authors:  H E Lee; D J Park; W H Kim; H H Kim; H S Lee
Journal:  Br J Cancer       Date:  2011-07-05       Impact factor: 7.640

9.  Intraoperative optical coherence tomography for assessing human lymph nodes for metastatic cancer.

Authors:  Ryan M Nolan; Steven G Adie; Marina Marjanovic; Eric J Chaney; Fredrick A South; Guillermo L Monroy; Nathan D Shemonski; Sarah J Erickson-Bhatt; Ryan L Shelton; Andrew J Bower; Douglas G Simpson; Kimberly A Cradock; Z George Liu; Partha S Ray; Stephen A Boppart
Journal:  BMC Cancer       Date:  2016-02-23       Impact factor: 4.430

10.  A negative binomial regression model for risk estimation of 0-2 axillary lymph node metastases in breast cancer patients.

Authors:  Hao-Yu Lin; Yu-Ling Zhang; Jun-Dong Wu; Kun Lin; Ya Xu; Chun-Fa Chen
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.